Liver, Pancreas, Esophagus, Gallbladder

66 Expert Conversations

    66 Expert Conversations
    Gastroesophageal reflux disease and esophageal cancer. 1
    0.00 NIS
    Patient’s story. Metastatic esophageal cancer. Success of double neoadjuvant chemotherapy. 12
    0.00 NIS
    Esophageal cancer treatment FAQ. Prognosis. When surgery is not beneficial? 11
    0.00 NIS
    Future in esophageal cancer treatment. Precision medicine. Tumor genome sequencing. 10
    0.00 NIS
    Esophageal carcinoma radiotherapy. ‘East’ vs. ‘West’ differences in radiotherapy use. 7
    0.00 NIS
    Esophageal carcinoma. Neoadjuvant chemotherapy vs. upfront surgery. 6
    0.00 NIS
    Esophageal carcinoma diagnosis. PET CT. Endoscopic ultrasound. Cure at early stage is possible. 5
    0.00 NIS
    GERD anti-reflux surgery often fails after 10 years. PPI medications and esophageal cancer risk. 3
    0.00 NIS
    Does GERD anti-reflux surgery reduce esophageal cancer risks? The risk does not go down to zero. 2
    0.00 NIS
    Dr. Jari Rasanen. Esophageal cancer and Lung cancer expert. Biography. 0
    0.00 NIS
    How to improve health of your liver? Difficulty to keep low weight. 16
    0.00 NIS
    FAQ from patients with fatty liver disease. Life quality, prognosis, alcohol use. 15
    0.00 NIS
    Future of liver disease treatment. Xenotransplantation of liver. 14
    0.00 NIS
    Coffee reduces risks of liver disease. Coffee and NAFLD prevention. 13
    0.00 NIS
    Leading drug candidates for NASH therapy. NAFLD, fatty liver disease treatment. 12
    0.00 NIS
    When new drugs will be approved for fatty liver disease? 11
    0.00 NIS
    Liver cancer risk and fatty liver disease. Cancer screening in NASH, NAFLD. 10
    0.00 NIS
    Hepatic Stellate Cells cause fatty liver disease. NAFLD and NASH causes. 9
    0.00 NIS
    Food supplements and generic drugs for NASH and NAFLD. 8
    0.00 NIS
    Gut microbiome and fatty liver disease. NAFLD, NASH, and Fecal transplantation. 7
    0.00 NIS
    Genetic tests to find risks for liver disease [NAFLD and NASH]. 6
    0.00 NIS
    How NASH differs from NAFLD. What drives progression to NASH? 5
    0.00 NIS
    Can fatty liver disease be reversed? NAFLD and NASH treatment. 4
    0.00 NIS
    Diagnostic tests for fatty liver disease, NAFLD. FibroScan and MR Elastography. 3
    0.00 NIS
    Non-obese patients with NAFLD [fatty liver disease]. ‘Lean NASH’. 2
    0.00 NIS
    What is Non-Alcoholic Fatty Liver Disease? NAFLD Diagnostic Criteria. 1
    0.00 NIS
    Dr. Scott L Friedman. Liver disease, NAFLD, NASH Expert. Biography. 0
    0.00 NIS
    Cancer surgery failures and challenges. Ovarian cancer. Eminent cancer surgeon.
    0.00 NIS
    Hypertension in diabetes and in metabolic syndrome. Best treatment options. 2
    0.00 NIS
    Pancreatic cancer screening. Liver cancer screening. 10
    0.00 NIS
    MRI of liver. MRCP of pancreas. MRCP or ERCP? 9
    0.00 NIS
    Chemotherapy selection for metastatic peritoneal cancer. Precision medicine selection. 14
    0.00 NIS
    How to overcome skeptics in work and in life? Leading cancer surgeon explains. 9
    0.00 NIS
    Stage 4 colon cancer. Liver or lung metastases. Locoregional treatment. DEBIRI TACE, IRE, SIRT. 7
    0.00 NIS
    Gallbladder cancer treatment options. 7
    0.00 NIS
    Best surgical treatment for liver cancer. Surgical technique from Japan. 5
    0.00 NIS
    Pancreatic cancer. Quality of life depends on local control of tumor. 4
    0.00 NIS
    Recently viewed Expert Conversations